- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04643275
Effect of BTL-899 Device for Non-invasive Lipolysis on Human Upper Arms
Study Overview
Detailed Description
The aim of the study is to confirm the efficacy and the safety of the treatment. The efficacy (reduction of excess adipose tissue) will be assessed via correct identification of pre-treatment and 3-months follow-up images by at least two out of three independent blinded evaluators. The fat reduction will be also measured by means of ultrasound. Comfort and satisfaction will be assessed via standard questionnaires.
Safety measures will include documentation of adverse events (AE) during and after the procedures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sofia, Bulgaria, 1700
- Dr Denkova Dermatology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body Mass Index (BMI) of 20 to 35 kg/m2.
- Visible excess of adipose tissue at the treatment site
- Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation.
- No procedure for fat reduction in the area in the last six months.
- Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting a significant change of weight in either direction during the study participation.
Exclusion Criteria:
- Electronic implants (such as cardiac pacemakers, defibrillators, and neurostimulators)
- Cardiovascular diseases
- Vascular diseases (such as chronic venous insufficiency, deep venous thrombosis, varicose veins, etc.)
- Disturbance of temperature or pain perception
- Pulmonary insufficiency
- Metal implants
- Drug pumps
- Malignant tumor
- Hemorrhagic conditions
- Septic conditions and empyema
- Acute inflammations
- Systemic or local infection such as osteomyelitis and tuberculosis
- Contagious skin disease
- Elevated body temperature
- Pregnancy
- Breastfeeding
- Injured or otherwise impaired muscles in the arms
- Scars, open lesions, and wounds at the treatment area
- Basedow's disease
- Previous liposuction in the treatment area in the last six months
- Any other disease or condition at the investigator's discretion, e.g. dislocated shoulder or carpal tunnel syndrome than can pose danger to the patient or compromise the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Non-invasive lipolysis of the upper arms
The treatment administration phase consists of four (4) treatment visits, delivered 5- 10 - days apart.
Each therapy session will last 30 minutes.
Follow-ups visits at 1 month and 3 months after the final treatment will be held.
|
Treatment with study device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Statistically significant reduction of fat thickness in the upper arms evaluated by photographs
Time Frame: 5 months
|
To gather clinical evidence that the BTL-899 device is able to induce non-invasive lipolysis when used on upper arms.
The primary efficacy outcome measure is a minimum 75% of the subjects' pre-treatment and 3-months follow-up images to be correctly identified by at least two of three independent blinded evaluators.
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of the Therapy's Safety Measured Via Therapy Comfort Questionnaire
Time Frame: 7 months
|
Assessment the safety of the BTL-899 device when used for non-invasive lipolysis of the upper arms via questionnaires filled in by the participants following each therapy session.
On Numerical Analog Scale (0-10), where 0 represents 'no pain' and 10 represents 'worst possible pain' select the level of pain experienced during the treatment.
The outcome will further be measured through the occurrence of adverse events or lack thereof.
|
7 months
|
Evaluation of the participants' satisfaction with the therapy evaluated via standard questionnaires
Time Frame: 5 months
|
Evaluation of the participants' satisfaction with the therapy and the results.
● Minimum 80% of treated subjects to report satisfaction (level satisfied and higher) with the therapy.
|
5 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BTL-899A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fat Burn
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.WithdrawnFat BurnUnited States, Bulgaria
-
São Paulo State UniversityUnknown
-
National Tainan Junior College of NursingCompleted
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.Active, not recruitingFat BurnUnited States
-
BTL Industries Ltd.Completed
-
National Taiwan UniversityCompleted
Clinical Trials on BTL-899
-
BTL Industries Ltd.CompletedImprovement of Abdomen AppearanceBulgaria
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedMuscle ToneUnited States
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedImprovement of Abdomen AppearanceBulgaria